In a report released yesterday, Anthony Vendetti from Maxim Group reiterated a Buy rating on Hain Celestial (HAIN – Research Report), with a price target of $30.00. The company’s shares closed yesterday at $10.25.
Vendetti covers the Healthcare sector, focusing on stocks such as Aethlon Medical, Icecure Medical, and Sientra. According to TipRanks, Vendetti has an average return of -3.8% and a 33.40% success rate on recommended stocks.
Hain Celestial has an analyst consensus of Hold, with a price target consensus of $14.33.
See Insiders’ Hot Stocks on TipRanks >>
The company has a one-year high of $22.14 and a one-year low of $9.36. Currently, Hain Celestial has an average volume of 981.7K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Hain Celestial Group, Inc. engages in the production and distribution of organic and natural products. It operates through the following geographical segments: United States, United Kingdom, Rest of World, and Corporate and Other. The United States segment comprises of baby, pantry, snack food, fresh, personal care, and tea products. The United Kingdom segment offers frozen and chilled products. The Rest of World segment distributes products in Canada and Europe. The Corporate and Other segment includes expenses related to the firm’s administrative functions. The company was founded by Irwin David Simon on May 19, 1993 and is headquartered in Lake Success, NY.
Read More on HAIN:
- Hain Celestial price target lowered to $11 from $13 at Stifel
- Hain Celestial unveils strategy to transform company
- Hain Celestial Unveils Strategy to Transform Company to Drive Sustainable Profitable Growth at 2023 Investor Day
- Hain Celestial to Host Investor Day Webcast
- Hain Celestial price target lowered to $13 from $14 at Evercore ISI
